Machine Learning (ML) in The Pharmaceutical Industry Market Revenue Growth Forecast To Reach $22.59 Billion By 2030 At 14.1% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Machine Learning (ML) in The Pharmaceutical Industry Market From 2026 To 2030?
The market size for machine learning (ml) in the pharmaceutical industry has seen significant expansion in recent years. It is anticipated to increase from $4.08 billion in 2025 to $5.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 35.4%. The historical growth of this market can be attributed to several factors, including heightened research and development investment in pharmaceuticals, the adoption of AI and ML in drug discovery processes, an increasing prevalence of chronic diseases, advancements in computational biology, and strategic collaborations between pharmaceutical and technology companies.
The market size for machine learning (ML) in the pharmaceutical industry is anticipated to demonstrate significant growth in the upcoming years. It is projected to expand to $18.71 billion by 2030, driven by a compound annual growth rate (CAGR) of 35.7%. This increase over the forecast period stems from the increasing integration of AI in clinical trials, the widening scope of precision medicine, the growing adoption of real-world data analytics, developments in cloud-based pharmaceutical platforms, and the creation of personalized therapeutics. Prominent trends for this period include predictive models for drug discovery, optimization of clinical trials, utilization of real-world evidence data, implementation of personalized medicine, and automation of regulatory compliance.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp
What Key Factors Are Shaping The Machine Learning (ML) in The Pharmaceutical Industry Market Landscape?
The growing implementation of artificial intelligence (AI) is a key factor driving machine learning (ML) within the pharmaceutical industry. AI refers to computer software designed to emulate human cognitive functions for executing complex operations such as analysis, reasoning, and learning, while ML is a subset of AI that employs algorithms trained on data to create models capable of performing intricate tasks. Both AI and ML have been applied in pharmaceutical technology and drug delivery system design, offering rapid solutions to complex problems. These technologies hold the potential to revolutionize the drug delivery process, enhance tools for decision-making, and manage extensive data volumes for more effective outcomes. For instance, in June 2023, according to Forbes, a US-based business magazine, approximately 432,000 UK organizations, or one in six, had integrated at least one AI technology. Furthermore, a minimum of one AI technology was adopted by 68% of large businesses, 33% of medium-sized businesses, and 15% of small businesses. Consequently, the increasing adoption of artificial intelligence (AI) is poised to propel machine learning (ML) forward in the pharmaceutical industry.
How Is The Machine Learning (ML) in The Pharmaceutical Industry Market Organized By Segment Classification?
The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –
1) By Component: Solution, Services
2) By Deployment: Cloud, On-premise
3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises
Subsegments:
1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications
2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services
What Market Trends Are Affecting The Machine Learning (ML) in The Pharmaceutical Industry Market?
Prominent companies operating with machine learning in the pharmaceutical industry are concentrating on creating user-friendly software platforms, like drug discovery software, to boost their capabilities in drug development. Drug discovery software is a comprehensive term that encompasses various specialized tools and platforms employed across the entire process of identifying and developing novel pharmaceutical drugs. As an illustration, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, unveiled the AIDDISON drug discovery software. This platform is recognized as the first software-as-a-service offering that combines drug discovery and synthesis by utilizing generative AI, machine learning, and computer-aided drug design. It empowers laboratories to identify appropriate drug candidates within a vast chemical space, virtually screen compounds from a universe of over 60 billion chemical targets, and assess synthesis routes for drug manufacturing that is safer, more cost-effective, and achieves higher yields.
Who Are The Industry Participants Involved In The Machine Learning (ML) in The Pharmaceutical Industry Market?
Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs
Get The Full Machine Learning (ML) in The Pharmaceutical Industry Market Report:
Which Region Dominates The Machine Learning (ML) in The Pharmaceutical Industry Market By Market Share?
North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Machine Learning (ML) in The Pharmaceutical Industry Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Machine Learning (ML) in The Pharmaceutical Industry Market 2026, By The Business Research Company
Machine Learning Ml In The Pharmaceutical Industry Market Report 2026
Artificial Intelligence In Drug Discovery Market Report 2026
Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
